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  when plotted with respect to the time  shows a steady decrease which is 
probably the usual case due to the presence of RNAse and other enzymes and 
proteins which degrade the complex.  
However, the presence of gold nanoparticle helps reduce the degradation process 
when compared to the presence of RNA without gold attached to it.  
Gold nanoparticles have been employed for in vitro, ex vivo and in vivo imaging 
applications but mainly for serving as scaffolds for therapeutic drug delivery systems. 
There is a dearth of information intertwined with drug delivery studies particularly the 
diffusion process through the membrane.  
Due to the various federal regulations, these experiments are not directly performed on 
live subjects and therefore there is a need for simulating the behavior of the processes.  
The information derived from the simulations can impact the drug delivery systems in a 
way that modifications can be done to produce better drug release and better specificity 
of the intended drug. From various wet lab research it is found that targeted drug 
delivery systems (TDDS) are more effective with the presence of SiRNA and AuNp 
complex. 
SiRNA and Gold Nanoparticle complex 
Small interfering RNA (SiRNA) has attracted attention in the field of nucleic acid 
medicine as a RNA interference (RNAi) application that leads to gene silencing due to 
specific messenger RNA (mRNA) destruction. However, since SiRNA is unstable in blood 
and unable to cross the cell membrane, binding/encapsulation of SiRNA into a carrier is 
required. 
 
Gold nanoparticles serve as an attractive carriers in the targeted drug delivery system 
(TDDS) due to their functional diversity, cytoxicity, and in vivo excretion properties. 
There are two ways of assembling SiRNA- AuNp complex covalent attachment and 
supramolecular assembly. We modeled the complex based on covalent assembly with 
partial covalent attachment (~35%) and electrostatic (~65%).   
 
Gold nanoparticle in this simulation studies is modeled with a diameter of 8nm in size 
and the SiRNA are attached to the gold sphere with partial covalent and electrostatic 
interaction.  
 
 
Figure 4: Plot of concentration vs. time graph in blood as media 
In Order to examine the stability of the SiRNA- AuNp complex in blood with respect 
to time as the variable the simulation was performed with defining the medium 
with the properties of blood with a greater diffusion coefficient.  
 
Under the transport of diluted species module, Time dependent studies was 
selected after assigning the values of initial concentrations of the species involved 
the concentration vs time graph was plotted. 
 
Since there are a lot of parameters which play a role in the stability of the complex 
for example the viscosity, diffusion coefficient, temperature etc., the values which 
are assigned to these parameters should be as precise and as accurate as possible.  
 
Results  
This poster is aimed at discussing the various interactions taking place in a SiRNA and 
gold nanoparticle  (SiRNA- AuNp)  complex with respect to time. SiRNA are widely used 
in the field of targeted drug delivery systems due to their higher specificity. The SiRNA- 
AuNp complex is know to have a higher transfection efficiency compared to that of the 
traditional methods. 
 
Figure 3: Modeled SiRNA-AuNp encapsulated by a sphere defined with   
the properties of blood. 
Figure 2: General binding of gold nanoparticles with SiRNA with thiol bond. 
Figure 1: Modeled SiRNA-AuNp complex using  COMSOL. 
Conclusion and Future work : 
The simulation performed gives data which is convincing and is practically close to 
that of experimental values. However, further work is being done to study the 
dynamics of the SiRNA-AuNp complex while diffusing through the membrane. The 
various parameters which reduce the transfection capability of the complex.  
The data generated through the above methods might be instrumental in 
developing better TDDS. By studying the role of electric field in the drug delivery 
process it can improve better drug release and also improve the stability of the 
complex, when the attachment is electrostatic. 
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